A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation()
Eline M. P. Cremers,Theo de Witte,Liesbeth C. de Wreede,Diderik Jan Eikema,Linda Koster,Anja van Biezen,Jürgen Finke,Gérard Socié,Dietrich W. Beelen,Johan Maertens,Arnon Nagler,Guido Kobbe,Dimitris Ziagkos,Maija Itälä-Remes,Tobias Gedde-Dahl,Jorge Sierra,Dietger Niederwieser,Per Ljungman,Yves Beguin,Zübeyde Nur Özkurt,Achilles Anagnostopoulos,Pavel Jindra,Marie Robin,Nicolaus Kröger +23 more
TL;DR: Patients with an expected prolonged survival after transplantation may benefit from early iron reduction therapy after transplanted red blood cell transfusions, as illustrated in the impact of RBCT and related parameters on HSCT-outcome.
Journal Article
Inappropriate antidiuretic hormone secretion (SIADH) preceding skin manifestations of disseminated varicella zoster virus infection post-BMT.
TL;DR: The syndrome of inappropriate antidiuretic hormone secretion (SIADH) preceding the development of skin lesions of varicella zoster virus (VZV) infection in a patient with CML 5 months post-allogeneic BMT is reported.
Journal ArticleDOI
Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation
Aida Inbal,Aida Inbal,Aharon Lubetsky,Aharon Lubetsky,Avichai Shimoni,Avichai Shimoni,R. Dardik,R. Dardik,Ben-Ami Sela,Ben-Ami Sela,R. Eskaraev,R. Eskaraev,I. Levi,I. Levi,I. Levi,N. S. Tov,N. S. Tov,Arnon Nagler +17 more
TL;DR: The results suggest that allo-SCT is not associated with increased hyper coagulability and addition of ATG to conditioning regimen has no significant procoagulant effect.
Journal ArticleDOI
Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia
Giorgia Battipaglia,Annalisa Ruggeri,Myriam Labopin,Liisa Volin,Didier Blaise,Gérard Socié,Reza Tabrizi,Jan J. Cornelissen,Ardeshir Ghavamzadeh,Anne Huynh,Depei Wu,Ibrahim Yakoub-Agha,Johan Maertens,Patrice Chevallier,Mohamad Mohty,Arnon Nagler +15 more
TL;DR: Different factors, modifiable or not, such as donor type, stem cell source, disease biology, and in vivo TCD, impact on GRFS and this may guide in the future transplant choices to improve morbidity and long-term quality of life.
Journal ArticleDOI
Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation.
Catherine J. Lee,Myriam Labopin,Dietrich W. Beelen,Jürgen Finke,Didier Blaise,Arnold Ganser,Maija Itälä-Remes,Patrice Chevallier,Hélène Labussière-Wallet,Johan Maertens,Ibrahim Yakoub-Agha,Jean Bourhis,Audrey Mailhol,Mohamad Mohty,Bipin N. Savani,Arnon Nagler +15 more
TL;DR: A large registry study that included 535 patients with t‐AML and prior solid tumor who underwent first MAC or RIC allogeneic HCT from 2000‐2016 found that LFS and OS were superior in patients receiving ablative regimens due to a decrease in relapse.